Joseph Ziegler - Aug 17, 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Principal Financial Officer
Signature
/s/ Joseph Ziegler
Stock symbol
TXMD
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/21/2023, 05:22 PM
Previous filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Award $0 +7.5K $0.00 7.5K Aug 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock of the Issuer are to be acquired upon the vesting of restricted stock units ("RSUs") granted to the Reporting Person. The RSUs shall fully vest on the earlier of August 17, 2024 or a Change in Control of the Issuer (as defined in the Issuer's 2019 Stock Incentive Plan).